RhoGAM prevents the Rh-negative
mother from making antibodies during her pregnancy. As long as the Rh-negative
mother receives RhoGAM appropriately during every pregnancy, her babies are at very low risk of developing hemolytic disease of the fetus and newborn (HDFN).
read more >>